Industry
Medical - Devices
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Loading...
Open
340.54
Mkt cap
9.4B
Volume
152K
High
340.54
P/E Ratio
-11.98
52-wk high
387.99
Low
329.07
Div yield
N/A
52-wk low
262.12
Portfolio Pulse from
December 12, 2024 | 12:15 pm
Portfolio Pulse from
December 10, 2024 | 12:15 pm
Portfolio Pulse from
November 27, 2024 | 12:15 pm
Portfolio Pulse from
November 20, 2024 | 12:15 pm
Portfolio Pulse from
November 18, 2024 | 12:15 pm
Portfolio Pulse from
November 11, 2024 | 12:15 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.